Particle.news

Download on the App Store

Sanders and King Introduce Bill to Ban Direct-to-Consumer Prescription Drug Ads

Lawmakers say the plan will shield patients from biased marketing in an industry that spends billions promoting high-priced drugs

vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, D.C.
Bernie Sanders questions witnesses during a hearing on Capitol Hill in March 2024 (Credit: Chip Somodevilla/Getty Images)

Overview

  • Four Democratic senators have cosponsored the measure, and it now awaits further action in the Senate
  • Drug companies poured more than $5 billion into television ads in 2024, accounting for over 30 percent of evening news commercial time
  • Senators highlighted that Novo Nordisk spent $263 million advertising Wegovy and charges nearly $1,000 a month for Ozempic in the U.S., compared with under $155 in countries that ban such ads
  • Researchers warn that over half of prescription drug ads contain misleading or false claims that may inflate patient demand
  • Proponents project a federal ban could raise up to $1.7 billion in annual tax revenue while curbing aggressive marketing tactics